Last reviewed · How we verify

NCT00586118

Inhalative Sedation in ICU With Sevoflurane Via Anaesthetic Conserving Device Compared to Propofol

Completed Last updated 3 January 2008
What this trial tests

trial testing Sevoflurane in Recovery From Sedation in 120 participants. Completed in 1 December 2007.

Timeline
1 December 2006
Primary endpoint
1 December 2007
1 December 2007

Quick facts

Lead sponsorKlinikum Ludwigshafen
StatusCompleted
Study typeOBSERVATIONAL
Enrollment120
Start date1 December 2006
Primary completion1 December 2007
Estimated completion1 December 2007

Drugs / interventions tested

Conditions studied

Sponsor

Klinikum Ludwigshafen — full company profile →

Who can join

Adults 18 to 80, any sex, with Recovery From Sedation or Sevoflurane Consumption. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The evaluation of the presented study will work on the practicability of inhalative sedation on the ICU, potential benefits and limitations of the ACD system in a postoperative sedated patient population in comparison to a standard intravenous sedation regimen with propofol, and focus on renal and hepatic function, cardioprotection and pharmacoeconomics

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Sevoflurane

Trials testing the same drug.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00586118.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing